Physician profile
Fanny Lee
NPI 1639162076
$2,418.48
in general payments reported to CMS, 2019-2025
15 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $17.24 · 2022: $306 · 2023: $383 · 2024: $301 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.03 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $512.53 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $388.28 | 2023-2025 | Clariti Contact Lens, Myday Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $319.60 | 2019-2025 | Air Optix, Simbrinza, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $295.09 | 2019-2025 | Acuvue |
| Abbvie INC. | $175.43 | 2022-2023 | |
| Glaukos Corporation | $174.77 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Optos, INC. | $112.13 | 2019 | |
| Dompe US, INC. | $111.36 | 2022-2025 | Oxervate |
| Oyster Point Pharma, INC. | $97.66 | 2022 | |
| Apellis Pharmaceuticals, INC. | $90.38 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $54.55 | 2024 | |
| Sight Sciences, INC. | $38.15 | 2023 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $21.27 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Visioneering Technologies, INC. | $10.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fanny Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.